Assay Service for assessing ADME properties and in vivo PK properties with the selected vendor. ENAMINE US INC
Combined Synopsis/Solicitation monitored from sam-gov.
- Buyer / agency
- HEALTH AND HUMAN SERVICES, DEPARTMENT OF
- Notice type
- Combined Synopsis/Solicitation
- Solicitation number
- 75N98026Q01193ENAMINEUSINCPCANIAAA08396
- Posted
- September 10, 2026
- Response deadline
- September 19, 2026
- Location
- MD, US
- Estimated value
- Not published by the source
- NAICS
- 424690
- Source
- sam-gov
Summary
The Section on Medicinal Chemistry (SMC) develops new molecular entities with implications in improving health and treatment for various metabolic and alcohol associated diseases. To assess the translational potential of novel molecular entities, which would allow us to make decisions to proceed the compounds for further development we utilize multiple derisking assays. These assays comprise of both cell-based (in vitro) testing and then eventually in mice to assess pharmacok…
See the official source link, all documents, and the full solicitation text — and prepare a proposal working draft with AI — with a free Octobid account.
Summaries are indexed from official public sources; the issuing platform’s notice, documents, and amendments always control.